The directors have a stack of their own money in this so have a lot at stake. The MD took up full rights in the previous issue so I guess he will do the same this time. He has also been buying heaps on market over the past 18 months. He is very confident about the prospects of this company. Success of the Proreka JV will sway my decision to participate in the rights issue. This I believe is expected before June 30.
ATJ Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held